Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1983 Sep;48(3):329–334. doi: 10.1038/bjc.1983.196

Treatment of advanced malignant melanoma with high-dose melphalan and autologous bone marrow transplantation.

M A Cornbleet, T J McElwain, P J Kumar, J Filshie, P Selby, R L Carter, D W Hedley, M L Clark, J L Millar
PMCID: PMC2011461  PMID: 6351883

Abstract

Twenty-eight patients with advanced life-threatening metastatic malignant melanoma were treated with high dose (140-260 mgm-2) intravenous melphalan and autologous bone marrow. Cyclophosphamide "priming" 300 mgm-2 i.v. was given to 19 patients one week previously and this resulted in clinical but not histological evidence of amelioration of gastrointestinal toxicity. In 11 patients (43%) there was evidence of tumour response to treatment and in 2 patients complete remissions were observed. However in most patients, responses were short-lived and no patient lived longer than 17 months from start of treatment or 24 months from first recorded evidence of distant metastatic disease.

Full text

PDF
329

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Botnick L. E., Hannon E. C., Hellman S. Nature of the hemopoietic stem cell compartment and its proliferative potential. Blood Cells. 1979 Jun 15;5(2):195–210. [PubMed] [Google Scholar]
  2. Hedley D. W., McElwain T. J., Millar J. L., Gordon M. Y. Acceleration of bone-marrow recovery by pre-treatment with cyclophosphamide in patients receiving high-dose melphalan. Lancet. 1978 Nov 4;2(8097):966–968. doi: 10.1016/s0140-6736(78)92529-1. [DOI] [PubMed] [Google Scholar]
  3. Luce J. K. Chemotherapy of melanoma. Semin Oncol. 1975 Jun;2(2):179–185. [PubMed] [Google Scholar]
  4. Millar J. L., Hudspith B. N., McElwain T. J., Phelps T. A. Effect of high-dose melphalan on marrow and intestinal epithelium in mice pretreated with cyclophosphamide. Br J Cancer. 1978 Jul;38(1):137–142. doi: 10.1038/bjc.1978.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Millar J. L., Phelps T. A., Carter R. L., McElwain T. J. Cyclophosphamide pretreatment reduces the toxic effect of high dose melphalan on intestinal epithelium in sheep. Eur J Cancer. 1978 Nov;14(11):1283–1285. doi: 10.1016/0014-2964(78)90236-0. [DOI] [PubMed] [Google Scholar]
  6. Rosendaal M., Hodgson G. S., Bradley T. R. Organization of haemopoietic stem cells: the generation-age hypothesis. Cell Tissue Kinet. 1979 Jan;12(1):17–29. doi: 10.1111/j.1365-2184.1979.tb00110.x. [DOI] [PubMed] [Google Scholar]
  7. Rosin R. D., Westbury G. Isolated limb perfusion for malignant melanoma. Practitioner. 1980 Oct;224(1348):1031–1036. [PubMed] [Google Scholar]
  8. SIMINOVITCH L., TILL J. E., MCCULLOCH E. A. DECLINE IN COLONY-FORMING ABILITY OF MARROW CELLS SUBJECTED TO SERIAL TRANSPLANTATION INTO IRRADIATED MICE. J Cell Physiol. 1964 Aug;64:23–31. doi: 10.1002/jcp.1030640104. [DOI] [PubMed] [Google Scholar]
  9. Selby P. J., Courtenay V. D., McElwain T. J., Peckham M. J., Steel G. G. Colony growth and clonogenic cell survival in human melanoma xenografts treated with chemotherapy. Br J Cancer. 1980 Sep;42(3):438–447. doi: 10.1038/bjc.1980.256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Thomas M. R., Robinson W. A., Glode L. M., Dantas M. E., Koeppler H., Morton N., Sutherland J. Treatment of advanced malignant melanoma with high-dose chemotherapy and autologous bone marrow transplantation. Preliminary results--Phase I study. Am J Clin Oncol. 1982 Dec;5(6):611–622. doi: 10.1097/00000421-198212000-00007. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES